| Cynthia J Kusiak, PA | |
|
2700 152nd Ave Ne, Redmond, WA 98052-5543 | |
| (425) 883-5151 | |
| Not Available |
| Full Name | Cynthia J Kusiak |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant - Medical |
| Location | 2700 152nd Ave Ne, Redmond, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194877431 | NPI | - | NPPES |
| 8407199 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | PA10001654 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cynthia J Kusiak, PA Po Box 34584, Seattle, WA 98124-1584 Ph: (509) 241-7349 | Cynthia J Kusiak, PA 2700 152nd Ave Ne, Redmond, WA 98052-5543 Ph: (425) 883-5151 |
News Archive
The Board of Directors of GNC Holdings, Inc. authorized and declared the quarterly cash dividend for the first quarter of 2015 of $0.18 per share of the Company's common stock, representing a 12.5% increase over its prior quarterly dividend.
This Kaiser Health News story by David Gulliver, produced in partnership with Health News Florida, explores how the impact of changes to Medicare Advantage will differ from place to place across the country.
Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it received approval from the US Food and Drug Administration for revised labeling for Alphanate Antihemophilic Factor/von Willebrand Factor Complex indicating that certain manufacturing steps have been shown to reduce the infectivity of a experimental TSE agent that is a model for variant Creutzfeldt Jakob Disease.
In preliminary experiments with mice and lab-grown cells, Johns Hopkins Kimmel Cancer Center scientists have found that a protein-signaling process accelerates the work of the gene most frequently mutated in a common form of adult leukemia and is likely necessary to bring about the full-blown disease.
Neptune Technologies & Bioressources Inc. subsidiary, Acasti Pharma Inc., reports the completion of its preclinical program designed to compare the lipid management effects of Acasti's drug candidate CaPre versus prescription drug Lovaza.
› Verified 2 days ago
Nathan Bushue, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 8301 161st Ave Ne Ste 202, Redmond, WA 98052 Phone: 425-996-8592 Fax: 425-968-5619 | |
Elizaveta Hermann, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 15809 Bear Creek Pkwy Ste 100, Redmond, WA 98052 Phone: 425-882-6100 Fax: 425-882-7690 | |
Colin O'brien, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 8980 161st Ave Ne Ste 320, Redmond, WA 98052 Phone: 425-883-3333 | |
Kamal Preet Saroya, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 8980 161st Ave Ne, Redmond, WA 98052 Phone: 425-883-3333 | |
Miss Sydney L Reames, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 15809 Bear Creek Pkwy Ste 100, Redmond, WA 98052 Phone: 425-882-6100 Fax: 844-660-0701 | |
Robert A Houk, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-883-5151 |